<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37071661</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Polyamines and eIF5A hypusination facilitate SREBP2 synthesis and cholesterol production leading to enhanced enterovirus attachment and infection.</ArticleTitle><Pagination><StartPage>e1011317</StartPage><MedlinePgn>e1011317</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1011317</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1011317</ELocationID><Abstract><AbstractText>Metabolism is key to cellular processes that underlie the ability of a virus to productively infect. Polyamines are small metabolites vital for many host cell processes including proliferation, transcription, and translation. Polyamine depletion also inhibits virus infection via diverse mechanisms, including inhibiting polymerase activity and viral translation. We showed that Coxsackievirus B3 (CVB3) attachment requires polyamines; however, the mechanism was unknown. Here, we report polyamines' involvement in translation, through a process called hypusination, promotes expression of cholesterol synthesis genes by supporting SREBP2 synthesis, the master transcriptional regulator of cholesterol synthesis genes. Measuring bulk transcription, we find polyamines support expression of cholesterol synthesis genes, regulated by SREBP2. Thus, polyamine depletion inhibits CVB3 by depleting cellular cholesterol. Exogenous cholesterol rescues CVB3 attachment, and mutant CVB3 resistant to polyamine depletion exhibits resistance to cholesterol perturbation. This study provides a novel link between polyamine and cholesterol homeostasis, a mechanism through which polyamines impact CVB3 infection.</AbstractText><CopyrightInformation>Copyright: © 2023 Firpo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Firpo</LastName><ForeName>Mason R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LoMascolo</LastName><ForeName>Natalie J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petit</LastName><ForeName>Marine J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Engineering, University of California, Davis, Davis, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Priya S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Engineering, University of California, Davis, Davis, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounce</LastName><ForeName>Bryan C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-1710-5362</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM138199</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007508</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011073">Polyamines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011073" MajorTopicYN="N">Polyamines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37071661</ArticleId><ArticleId IdType="pmc">PMC10146511</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1011317</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-22-02024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mounce BC, Olsen ME, Vignuzzi M, Connor JH. Polyamines and Their Role in Virus Infection. Microbiol Mol Biol Rev MMBR. 2017;81. doi: 10.1128/MMBR.00029-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00029-17</ArticleId><ArticleId IdType="pmc">PMC5706744</ArticleId><ArticleId IdType="pubmed">28904024</ArticleId></ArticleIdList></Reference><Reference><Citation>Burri C, Brun R. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res. 2003;90 Supp 1: S49–52. doi: 10.1007/s00436-002-0766-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00436-002-0766-5</ArticleId><ArticleId IdType="pubmed">12811548</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Cooper HL, Folk JE. Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc Natl Acad Sci U S A. 1981;78: 2869–2873. doi: 10.1073/pnas.78.5.2869</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.78.5.2869</ArticleId><ArticleId IdType="pmc">PMC319460</ArticleId><ArticleId IdType="pubmed">6789324</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Joe YA, Kang KR, Lee YB, Wolff EC. The polyamine-derived amino acid hypusine: its post-translational formation in eIF-5A and its role in cell proliferation. Amino Acids. 1996;10: 109–121. doi: 10.1007/BF00806584</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00806584</ArticleId><ArticleId IdType="pubmed">24178473</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Wolff EC. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation. J Biol Chem. 2018;293: 18710–18718. doi: 10.1074/jbc.TM118.003341</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.003341</ArticleId><ArticleId IdType="pmc">PMC6290153</ArticleId><ArticleId IdType="pubmed">30257869</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller AP, Wu CC-C, Dever TE, Buskirk AR, Green R. eIF5A Functions Globally in Translation Elongation and Termination. Mol Cell. 2017;66: 194–205.e5. doi: 10.1016/j.molcel.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5414311</ArticleId><ArticleId IdType="pubmed">28392174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez E, Shin B-S, Woolstenhulme CJ, Kim J-R, Saini P, Buskirk AR, et al.. eIF5A Promotes Translation of Polyproline Motifs. Mol Cell. 2013;51: 35–45. doi: 10.1016/j.molcel.2013.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.04.021</ArticleId><ArticleId IdType="pmc">PMC3744875</ArticleId><ArticleId IdType="pubmed">23727016</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Agostino M, Motta S, Romagnoli A, Orlando P, Tiano L, La Teana A, et al.. Insights Into the Binding Mechanism of GC7 to Deoxyhypusine Synthase in Sulfolobus solfataricus: A Thermophilic Model for the Design of New Hypusination Inhibitors. Front Chem. 2020;8: 1170. doi: 10.3389/fchem.2020.609942</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2020.609942</ArticleId><ArticleId IdType="pmc">PMC7773846</ArticleId><ArticleId IdType="pubmed">33392152</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Vlajnić L, Vidiņa A, Vallet T, Weger-Lucarelli J, et al.. Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness. J Virol. 2017;91. doi: 10.1128/JVI.00344-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00344-17</ArticleId><ArticleId IdType="pmc">PMC5512238</ArticleId><ArticleId IdType="pubmed">28539441</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Cressey TN, Mühlberger E, Connor JH. Differential Mechanisms for the Involvement of Polyamines and Hypusinated eIF5A in Ebola Virus Gene Expression. J Virol. 2018;92. doi: 10.1128/JVI.01260-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01260-18</ArticleId><ArticleId IdType="pmc">PMC6158423</ArticleId><ArticleId IdType="pubmed">30045993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrodomenico V, Esin JJ, Graham ML, Tate PM, Hawkins GM, Sandler ZJ, et al.. Polyamine depletion inhibits bunyavirus infection via generation of noninfectious interfering virions. J Virol. 2019; JVI.00530-19. doi: 10.1128/JVI.00530-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00530-19</ArticleId><ArticleId IdType="pmc">PMC6600196</ArticleId><ArticleId IdType="pubmed">31043534</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo MR, Mastrodomenico V, Hawkins GM, Prot M, Levillayer L, Gallagher T, et al.. Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry. ACS Infect Dis. 2020; acsinfecdis.0c00491. doi: 10.1021/acsinfecdis.0c00491</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00491</ArticleId><ArticleId IdType="pmc">PMC7539557</ArticleId><ArticleId IdType="pubmed">32966040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dial CN, Tate PM, Kicmal TM, Mounce BC. Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity. Viruses. 2019;11: 403. doi: 10.3390/v11050403</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050403</ArticleId><ArticleId IdType="pmc">PMC6563312</ArticleId><ArticleId IdType="pubmed">31052199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicmal TM, Tate PM, Dial CN, Esin JJ, Mounce BC. Polyamine depletion abrogates enterovirus cellular attachment. J Virol. 2019; JVI.01054-19. doi: 10.1128/JVI.01054-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01054-19</ArticleId><ArticleId IdType="pmc">PMC6798109</ArticleId><ArticleId IdType="pubmed">31341056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsebosch BM, Mounce BC. Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro. Viruses. 2021;13: 310. doi: 10.3390/v13020310</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020310</ArticleId><ArticleId IdType="pmc">PMC7920041</ArticleId><ArticleId IdType="pubmed">33669273</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Parker EPK, Grassly NC. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr Opin Infect Dis. 2015;28: 479–487. doi: 10.1097/QCO.0000000000000187</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Massilamany C, Gangaplara A, Reddy J. Intricacies of cardiac damage in coxsackievirus B3 infection: Implications for therapy. Int J Cardiol. 2014;177: 330–339. doi: 10.1016/j.ijcard.2014.09.136</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.09.136</ArticleId><ArticleId IdType="pmc">PMC4403007</ArticleId><ArticleId IdType="pubmed">25449464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim K-S. Persistent Coxsackievirus Infection: Enterovirus Persistence in Chronic Myocarditis and Dilated Cardiomyopathy. Group B Coxsackieviruses. Springer, Berlin, Heidelberg; 2008. pp. 275–292.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi FS, Marchant D, Hendry R, Luo H, Yang D, Ye X, et al.. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10: 629–653. doi: 10.2217/fmb.15.5</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Archard LC, Bowles NE, Cunningham L, Freeke CA, Olsen EGJ, Rose ML, et al.. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J. 1991;12: 56–59. doi: 10.1093/eurheartj/12.suppl_d.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/12.suppl_d.56</ArticleId><ArticleId IdType="pubmed">1655452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, et al.. Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J Virol. 2016;90: 9683–9692. doi: 10.1128/JVI.01347-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-16</ArticleId><ArticleId IdType="pmc">PMC5068521</ArticleId><ArticleId IdType="pubmed">27535047</ArticleId></ArticleIdList></Reference><Reference><Citation>Danthi P, Chow M. Cholesterol Removal by Methyl-β-Cyclodextrin Inhibits Poliovirus Entry. J Virol. 2004;78: 33–41. doi: 10.1128/JVI.78.1.33-41.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.1.33-41.2004</ArticleId><ArticleId IdType="pmc">PMC303393</ArticleId><ArticleId IdType="pubmed">14671085</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart AD, Eustace HE, McKee TA, Brown TDK. A Novel Cell Entry Pathway for a DAF-Using Human Enterovirus Is Dependent on Lipid Rafts. J Virol. 2002;76: 9307–9322. doi: 10.1128/jvi.76.18.9307-9322.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.18.9307-9322.2002</ArticleId><ArticleId IdType="pmc">PMC136471</ArticleId><ArticleId IdType="pubmed">12186914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilnytska O, Santiana M, Hsu N-Y, Du W-L, Chen Y-H, Viktorova EG, et al.. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe. 2013;14: 281–293. doi: 10.1016/j.chom.2013.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.08.002</ArticleId><ArticleId IdType="pmc">PMC3802520</ArticleId><ArticleId IdType="pubmed">24034614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et al.. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci. 1993;90: 11603–11607. doi: 10.1073/pnas.90.24.11603</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.24.11603</ArticleId><ArticleId IdType="pmc">PMC48032</ArticleId><ArticleId IdType="pubmed">7903453</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Yang H, Song B-L. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21: 225–245. doi: 10.1038/s41580-019-0190-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0190-7</ArticleId><ArticleId IdType="pubmed">31848472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirinen E, Gylling H, Itkonen P, Yaluri N, Heikkinen S, Pietilä M, et al.. Activated polyamine catabolism leads to low cholesterol levels by enhancing bile acid synthesis. Amino Acids. 2010;38: 549–560. doi: 10.1007/s00726-009-0416-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-009-0416-7</ArticleId><ArticleId IdType="pubmed">19956992</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AP, Morrissey RL, Crowell JA, Levine BS. Difluoromethylornithine in combination with tamoxifen in female rats: 13-week oral toxicity study. Cancer Chemother Pharmacol. 1999;44: 475–483. doi: 10.1007/s002800051121</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002800051121</ArticleId><ArticleId IdType="pubmed">10550568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu F, Liang Q, Abi-Mosleh L, Das A, Brabander JKD, Goldstein JL, et al.. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. eLife. 2015;4. doi: 10.7554/eLife.12177</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.12177</ArticleId><ArticleId IdType="pmc">PMC4718804</ArticleId><ArticleId IdType="pubmed">26646182</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo MR, Mounce BC. Diverse Functions of Polyamines in Virus Infection. Biomolecules. 2020;10: 628. doi: 10.3390/biom10040628</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10040628</ArticleId><ArticleId IdType="pmc">PMC7226272</ArticleId><ArticleId IdType="pubmed">32325677</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi K, Kashiwagi K. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun. 2000;271: 559–564. doi: 10.1006/bbrc.2000.2601</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.2601</ArticleId><ArticleId IdType="pubmed">10814501</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi K, Kashiwagi K. The functional role of polyamines in eukaryotic cells. Int J Biochem Cell Biol. 2019;107: 104–115. doi: 10.1016/j.biocel.2018.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2018.12.012</ArticleId><ArticleId IdType="pubmed">30578954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauc M, Cougnon M, Carcy R, Melis N, Hauet T, Pellerin L, et al.. The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles. Cell Biosci. 2021;11: 219. doi: 10.1186/s13578-021-00733-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00733-y</ArticleId><ArticleId IdType="pmc">PMC8705083</ArticleId><ArticleId IdType="pubmed">34952646</ArticleId></ArticleIdList></Reference><Reference><Citation>Dever TE, Gutierrez E, Shin B-S. The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol. 2014;49: 413–425. doi: 10.3109/10409238.2014.939608</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409238.2014.939608</ArticleId><ArticleId IdType="pmc">PMC4183722</ArticleId><ArticleId IdType="pubmed">25029904</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D, Galvão FC, Bellato HM, Boldrin PEG, Andrews BJ, Valentini SR, et al.. eIF5A has a function in the cotranslational translocation of proteins into the ER. Amino Acids. 2014;46: 645–653. doi: 10.1007/s00726-013-1618-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-013-1618-6</ArticleId><ArticleId IdType="pubmed">24306454</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulescu L, Wubbolts R, van Kuppeveld FJM, Strating JRPM. Cholesterol shuttling is important for RNA replication of coxsackievirus B3 and encephalomyocarditis virus. Cell Microbiol. 2015;17: 1144–1156. doi: 10.1111/cmi.12425</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12425</ArticleId><ArticleId IdType="pubmed">25645595</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizaki H, Morikawa K, Fukasawa M, Hara H, Inoue Y, Tani H, et al.. Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection. J Virol. 2008;82: 5715–5724. doi: 10.1128/JVI.02530-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02530-07</ArticleId><ArticleId IdType="pmc">PMC2395132</ArticleId><ArticleId IdType="pubmed">18367533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology. 2017;510: 234–241. doi: 10.1016/j.virol.2017.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.07.024</ArticleId><ArticleId IdType="pmc">PMC5571833</ArticleId><ArticleId IdType="pubmed">28750327</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro AC, Damonte EB. Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res. 2013;174: 78–87. doi: 10.1016/j.virusres.2013.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.03.005</ArticleId><ArticleId IdType="pubmed">23517753</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton FW, Hover S, Fuller J, Hewson R, Fontana J, Barr JN, et al.. Cellular cholesterol abundance regulates potassium accumulation within endosomes and is an important determinant in bunyavirus entry. J Biol Chem. 2019;294: 7335–7347. doi: 10.1074/jbc.RA119.007618</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.007618</ArticleId><ArticleId IdType="pmc">PMC6509484</ArticleId><ArticleId IdType="pubmed">30804209</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger SE, Kim C, Zhang L, Marjomaki V, Bergelson JM. Echovirus 1 Entry into Polarized Caco-2 Cells Depends on Dynamin, Cholesterol, and Cellular Factors Associated with Macropinocytosis. J Virol. 2013;87: 8884–8895. doi: 10.1128/JVI.03415-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03415-12</ArticleId><ArticleId IdType="pmc">PMC3754084</ArticleId><ArticleId IdType="pubmed">23740983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Poirier EZ, Passoni G, Simon-Loriere E, Cesaro T, Prot M, et al.. Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine Depletion Restrict Zika and Chikungunya Viruses. Cell Host Microbe. 2016;20: 167–177. doi: 10.1016/j.chom.2016.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.06.011</ArticleId><ArticleId IdType="pubmed">27427208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Liang X, Scott GK, Chang CH, Baldwin MA, Thomas T, et al.. Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions. Breast Cancer Res Treat. 1998;48: 243–257. doi: 10.1023/a:1005949319064</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1005949319064</ArticleId><ArticleId IdType="pubmed">9598871</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayanathan V, Thomas TJ, Nair SK, Shirahata A, Gallo MA, Thomas T. Bending of the estrogen response element by polyamines and estrogen receptors alpha and beta: a fluorescence resonance energy transfer study. Int J Biochem Cell Biol. 2006;38: 1191–1206. doi: 10.1016/j.biocel.2005.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2005.12.015</ArticleId><ArticleId IdType="pubmed">16767802</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Filone CM, Rozelle D, Mire CE, Agans KN, Hensley L, et al.. Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication. mBio. 2016;7. doi: 10.1128/mBio.00882-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00882-16</ArticleId><ArticleId IdType="pmc">PMC4981715</ArticleId><ArticleId IdType="pubmed">27460797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cáceres CJ, Angulo J, Contreras N, Pino K, Vera-Otarola J, López-Lastra M. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5’untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs. Antiviral Res. 2016;134: 192–206. doi: 10.1016/j.antiviral.2016.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.09.006</ArticleId><ArticleId IdType="pubmed">27633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque M, Hanauske-Abel HM, Palumbo P, Saxena D, D’Alliessi Gandolfi D, Park MH, et al.. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A. Retrovirology. 2009;6: 90. doi: 10.1186/1742-4690-6-90</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-6-90</ArticleId><ArticleId IdType="pmc">PMC2770518</ArticleId><ArticleId IdType="pubmed">19825182</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Connor JH. Hypusination of eIF5A as a Target for Antiviral Therapy. DNA Cell Biol. 2017;36: 198–201. doi: 10.1089/dna.2016.3611</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2016.3611</ArticleId><ArticleId IdType="pmc">PMC5346904</ArticleId><ArticleId IdType="pubmed">28080131</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al.. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29: 15–21. doi: 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31: 166–169. doi: 10.1093/bioinformatics/btu638</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15: 550. doi: 10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens M. False discovery rates: a new deal. Biostatistics. 2017;18: 275–294. doi: 10.1093/biostatistics/kxw041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxw041</ArticleId><ArticleId IdType="pmc">PMC5379932</ArticleId><ArticleId IdType="pubmed">27756721</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. 2021. Feb p. 060012. doi: 10.1101/060012</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/060012</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27: 1739–1740. doi: 10.1093/bioinformatics/btr260</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>